Harbour Investments, Inc. Catalent, Inc. Transaction History

Harbour Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$44.2 - $50.2 $3,403 - $3,865	-77 Reduced 70.0%	33 $1,000
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $8,474 - $17,891	-266 Reduced 70.74%	110 $4,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $8,679 - $14,183	191 Added 103.24%	376 $24,000
Q4 2021 Feb 16, 2022	BUY	$119.57 - $139.07 $1,076 - $1,251	9 Added 5.11%	185 $24,000
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $1,310 - $1,708	-12 Reduced 6.38%	176 $23,000
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $10,937 - $12,610	-109 Reduced 36.7%	188 $20,000
Q1 2021 Aug 17, 2021	BUY	$101.51 - $125.27 $30,148 - $37,205	297 New	297 $31,000

511

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.